IDNNA

IDNNA

Names
Preferred IUPAC name 1-(4-Iodo-2,5-dimethoxyphenyl)-N,N-dimethylpropan-2-amine
Other names 2,5-Dimethoxy-4-iodo-N,N-dimethylamphetamine 2,5-Dimethoxy-4-iodo-1-ethyl-(α-methyl)amine; N,N-Dimethyl-DOI
Identifiers
CAS Number	85563-10-6  Y
3D model (JSmol)	Interactive image
ChEMBL	ChEMBL11043  Y
ChemSpider	119009  Y
PubChem CID	135056
UNII	M6Q9NK9RFD  Y
CompTox Dashboard (EPA)	DTXSID901006121
InChI InChI=1S/C13H20INO2/c1-9(15(2)3)6-10-7-13(17-5)11(14)8-12(10)16-4/h7-9H,6H2,1-5H3 Y Key: XBCUSBRGRALQID-UHFFFAOYSA-N Y InChI=1/C13H20INO2/c1-9(15(2)3)6-10-7-13(17-5)11(14)8-12(10)16-4/h7-9H,6H2,1-5H3 Key: XBCUSBRGRALQID-UHFFFAOYAY
SMILES Ic1cc(OC)c(cc1OC)CC(N(C)C)C
Properties
Chemical formula	C13H20NO2I
Molar mass	349.211 g/mol
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). Y  verify  (what is  YN ?) Infobox references

IDNNA, also known as 2,5-dimethoxy-4-iodo-N,N-dimethylamphetamine or as N,N-dimethyl-DOI, is a lesser-known psychedelic drug and a substituted amphetamine. It is also the N,N-dimethyl analog of DOI. IDNNA was first synthesized by Alexander Shulgin. In his book PiHKAL , the minimum dosage is listed as 2.6 mg, and the duration unknown. ^[1] IDNNA produces few to no effects. Very little data exists about the pharmacological properties, metabolism, and toxicity of IDNNA.

Society and culture

Legal status

United Kingdom

This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act. ^[2]

See also

• DOx (psychedelics)
• N-Methyl-DOI
• Methyl-DOB (N-methyl-DOB)
• N-Methyl-2C-I
• N-Methyl-2C-B
• Beatrice (N-methyl-DOM)
• N-Methyl-DOET

References

1. IDNNA Entry in PiHKAL
2. "UK Misuse of Drugs act 2001 Amendment summary". Isomer Design. Archived from the original on 22 October 2017. Retrieved 12 March 2014.

External links

• IDNNA - Isomer Design